Pure Global
NCT05427357

Evaluation of the Results of Closed Kinetic Chain Exercises in Patellofemoral Pain Syndrome

Evaluation of The Results of Closed Kinetic Chain Exercises Applied in The Conservative Treatment of Patellofemoral Pain Syndrome by Means of Shear Wave Elastography: A Randomized Controlled Trial
Taksim Egitim ve Arastirma Hastanesi·ClinicalTrials.gov·otherCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Exercise Training
Drug/Device/Intervention
Non-selective closed kinetic chain exercises (NSKCE) and selective closed kinetic chain exercises (SCKCE)
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Taksim Egitim ve Arastirma Hastanesi
Timeline & enrollment
Phase
N/A
Start date
Dec 01, 2016
End date
Feb 01, 2018
Enrollment
80 participants
Primary outcome

Shear Wave Elastography,Shear Wave Elastography

Summary

Non-selective closed kinetic chain exercises and or selective closed kinetic chain exercises
 has been shown to increase Vastus medialis obliquus muscle power in patellofemoral pain
 syndrome. However, the superiority of the exercises to each other has not been shown.
 
 This study aimed to evaluating the effects of different exercises on the stiffness of the
 Vastus medialis obliquus and vastus lateralis muscles, pain management, functional scores,
 and thigh circumferences.

ICD-10 classifications
Orthoptic trainingLack of physical exerciseOther physical therapyCardiac rehabilitationExhaustion due to excessive exertion
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05427357
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05427357 through Pure Global AI's free database. This phase not specified trial is sponsored by Taksim Egitim ve Arastirma Hastanesi and is currently Completed. The study focuses on Exercise Training. Target enrollment is 80 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.